Brief: Sernova announces $2,000,000 first closing of private placement
27/06/2016 11:00
June 27 (Reuters) - Sernova
* Net proceeds will be used to fund co's regenerative
medicine clinical program & collaborations
* Sernova announces $2,000,000 first closing of private
placement
Source text for Eikon: ID:nCCN2DmYCt
Further company coverage: SVA.V
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Sernova Biotherapeutics
See all newsBrief: Seraxis And Sernova Announce Appointment Of Former FDA Medical Officer Dr. Patricia Beaston As Chief Medical Officer Of Seraxis And Post Merger Betanova Biotherapeutics
Brief: Sernova Appoints Jonathan Rigby As Interim Chair
Brief: Sernova Biotherapeutics Provides Positive Interim Data From Ongoing Phase 1/2 Clinical Trial Of Cell Pouch Bio-Hybrid Organ In Patients Living With Type 1 Diabetes
Brief: Sernova Biotherapeutics Secures $4 Million Loan To Further Advance Its Clinical Development Plans
Brief: Sernova Biotherapeutics Inc Study Is On Track To Meet Key Clinical Trial Endpoints